Google tests healthcare ads in AI Mode
Google has confirmed that it is testing healthcare ads in AI Mode. With this move, the search giant marks another step in expanding ad formats across its AI-powered search experiences. For SEO and performance marketing teams, the test is more than industry background noise: it offers early signals on how Google intends to monetize AI search and which rules may apply to heavily regulated verticals.
The confirmation follows weeks of industry speculation that healthcare ads had already started appearing in AI-generated search surfaces. Google Ads Liaison Ginny Marvin explained on LinkedIn that Google is beginning a small test of ads in AI Mode for the healthcare vertical. The news arrives at a time when AI Overviews and AI Mode are increasingly shaping classic organic and paid search traffic.
Scope of the test and geographic limits
The test is tightly scoped for now. According to Marvin, it applies only to healthcare advertisers in the United States and only to English-language queries in AI Mode. That keeps the rollout limited to one market and one language, which is typical for early Google experiments. Advertisers outside the U.S. will not see immediate effects, but they can infer how Google may proceed when additional regions follow.
For marketers in healthcare, the geographic restriction is still relevant. The U.S. is one of the most important and simultaneously most heavily regulated advertising markets for pharma, medical technology, and health services. That Google is starting there signals the company is considering compliance requirements from the outset rather than pushing ads broadly into all AI surfaces.
Which campaign types can participate
Marvin named several campaign types eligible for the test. These include Performance Max, AI Max with search term matching, Shopping campaigns, and broad match campaigns. According to Google, the same formats are also eligible to serve ads in AI Overviews. For teams already relying on PMax or AI Max, this means existing campaign structures could eventually be delivered in AI search surfaces without a complete rebuild.
Performance Max and AI Max in focus
Performance Max bundles ads across multiple Google channels and is widely used as a default format. AI Max extends automated control with AI-powered keyword matching. That both formats are included in the healthcare test fits Google's strategy of scaling automation and machine learning even in sensitive verticals. Shopping campaigns and broad match suggest Google is testing not only text-based ads but also product-oriented formats in AI Mode.
For SEO leads, this raises an interface question: if paid healthcare content appears in AI Mode alongside organic answers, visibility logic shifts. Brands will need to weigh more carefully which topics they cover organically and where paid media complements AI surfaces. The test is therefore also a signal for GEO strategies, because generative search surfaces can establish new placement rules.
Why healthcare matters as a test vertical
Healthcare is one of Google's most heavily regulated advertising categories. Ads are subject to strict rules on medical claims, approvals, and transparency. That Google is starting in this segment makes the test a stress test for both monetization and trust. Advertisers in other regulated industries such as financial services or insurance can infer how Google may handle compliance and ad placement in AI results going forward.
If the rollout expands, healthcare marketers could gain access to a new visibility source in AI Mode. At the same time, pressure grows to design creatives and landing pages that both meet policy requirements and perform in generative contexts. For agencies and in-house teams, that means additional coordination between legal, medical affairs, and performance marketing.
Creative restrictions in the first phase
The test does not start without constraints. Marvin explained that the first phase allows only ads that do not use pinned assets or text disclaimers. Pinned assets are fixed headlines, descriptions, or images in responsive ads. Disclaimers are often mandatory in healthcare advertising to display legal notices visibly. Excluding both for now significantly narrows the pool of eligible creatives.
Advertisers with disclaimer-heavy ads must therefore check whether their existing assets qualify for the test at all. That can create short-term gaps in delivery, but it also explains why Google is proceeding cautiously. In regulated industries, missing or incorrectly placed notices pose significant risk for both the platform and advertisers.
What marketers should watch now
The test is still small by Google's own framing, but the industry will watch closely. Key questions are whether Google expands participation to more healthcare advertisers, unlocks additional ad formats, and includes other regulated industries. When disclaimers and pinned assets will be allowed again is also central to long-term planning.
Beyond that, the move provides an early indication of how Google plans to balance monetization and user trust in AI Mode. AI search promises fast, summarized answers. Advertising in this context must feel helpful without undermining the credibility of responses. Senior Strategist Ben Goldman first flagged the test in a LinkedIn discussion about GML 2026 takeaways before Google responded officially.
For SEO, GEO, and paid media teams, it pays to view AI Mode and AI Overviews together. Both surfaces share eligible campaign types and could eventually form a connected advertising ecosystem in generative search. Teams that prepare tracking, reporting, and creative compliance for AI placements now will be better positioned once Google expands the test or adds new markets.
